Valganciclovir (AvKARE, Inc.)
Welcome to the PulseAid listing for the Valganciclovir drug offered from AvKARE, Inc.. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
| NON-PROPRIETARY NAME: | Valganciclovir hydrochloride |
| SUBSTANCE NAME: | VALGANCICLOVIR HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-06-21 |
| END MARKETING DATE: | 0000-00-00 |
Valganciclovir HUMAN PRESCRIPTION DRUG Details:
| Item Description | Valganciclovir from AvKARE, Inc. |
| LABELER NAME: | AvKARE, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 450(mg/1) |
| START MARKETING DATE: | 2016-06-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42291-875_b5c5b9d1-ab0b-bc8c-294f-90355838ca9c |
| PRODUCT NDC: | 42291-875 |
| APPLICATION NUMBER: | ANDA200790 |
Other VALGANCICLOVIR HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
